Sanofi
Foreign companies in China feel unfairly singled out by government probes
European Chamber of Commerce in China says accusations get more publicity from state-controlled media.
-
$425M Dermik buy broadens Valeant’s dermatology business
Valeant Pharmaceuticals International Inc. is adding to its dermatology business with the acquisition of Dermik, a dermatology unit of Sanofi, for $425 million.
